Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

QuidelOrtho VITROS™ Immunodiagnostic Products Anti-SARS-CoV-2 Total Controls

Catalog No. OCD6199924
Click to view available options
Quantity:
3 Sets
This item is not returnable. View return policy
Rx ONLY. For in vitro diagnostic and Laboratory Professional use. For emergency authorization use only.
This item is not returnable. View return policy
Rx ONLY. For in vitro diagnostic and Laboratory Professional use. For emergency authorization use only.

Used for the qualitative measurement of total antibody (including IgG and IgM) to SARS-CoV-2 in human serum and plasma (K2 EDTA) samples from patients suspected of COVID-19 by a healthcare provider, using VITROS™ ECi/ECiQ/3600 Immunodiagnostic Systems and the VITROS™ 5600/XT 7600 Integrated Systems.

The VITROS™ Immunodiagnostic Products Anti-SARS-CoV-2 Total test is performed using the VITROS™ Anti-SARS-CoV-2 Total Reagent Pack and the VITROS™ Anti-SARS-CoV-2 Total Calibrator on the VITROS™ ECi/ECiQ/3600 Immunodiagnostic System and the VITROS™ 5600/XT 7600 Integrated Systems.

An immunometric technique is used; this involves a two stage reaction:

  • In the first stage antibodies to SARS-CoV-2 present in the sample bind with SARS-CoV-2 spike protein antigen coated on the well. Unbound sample is removed by washing.
  • In the second stage horseradish peroxidase (HRP)-labeled recombinant SARS-CoV-2 antigen is added in the conjugate reagent. The conjugate binds specifically to any anti-SARSCoV-2 captured on the well in the first stage. Unbound conjugate is removed by the subsequent wash step.
  • The bound HRP conjugate is measured by a luminescent reaction. A reagent containing luminogenic substrates (a luminol derivative and a peracid salt) and an electron transfer agent is added to the wells. The HRP in the bound conjugate catalyzes the oxidation of the luminol derivative, producing light. The electron transfer agent (a substituted acetanilide) increases the level of light produced and prolongs its emission. The light signals are read by the system. The amount of HRP conjugate bound is indicative of the amount of SARS-CoV-2 antibody present.

Control Contents (Part No. 6199924):

  • 3 sets of VITROS Anti‐SARS-CoV-2 Total Controls

Required but not included:

  • VITROS™ Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack (Part No. 6199922)
  • VITROS™ Immunodiagnostic Products Anti-SARS-CoV-2 Total Calibrator (Part No. 6199923)
  • VITROS™ Immunodiagnostic Products Signal Reagent
  • VITROS™ Immunodiagnostic Products Universal Wash Reagent
  • VITROS™ Immunodiagnostic Products Reagent Pack Storage Box (optional) with desiccant

Specifications

Content And Storage 2°C to 8°C
For Use With (Equipment) VITROS ECi/ECiQ/3600 Immunodiagnostic Systems and VITROS 5600/XT 7600 Integrated Systems
Sample Type Serum, Plasma
For Use With (Application) Detection of total SARS-CoV-2 antibodies
Packaging 3 Sets
Quantity 3 Sets
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.